Patents
Patents for C07C 233 - Carboxylic acid amides (28,881)
01/2003
01/07/2003CA2124784C Pentanoic acid derivatives
01/07/2003CA2049563C Production of b-hydroxyalkylamides
01/03/2003WO2003000698A1 β-BENZYLOXYASPARTATE DERIVATIVES WITH AMINO GROUP ON BENZENE RING
01/03/2003WO2003000649A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
01/03/2003WO2003000648A1 Fragrance compounds
01/03/2003WO2003000647A1 (ethylene)-(propylene)-triaminepentaacetic acid derivatives, process for their production, and their use for the production of pharmaceutical agents
01/03/2003WO2003000173A2 Use of branched-chain fatty acids and derivatives thereof for the treatment of pain
01/03/2003CA2450174A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
01/02/2003US20030004367 Such as (Z)-4-(tert-butylamino)-4-oxo-2-butenoic acid; protective coatings for use as two-part liquid pavement markings
01/02/2003US20030004360 Processes and intermediates for preparing benzyl epoxides
01/02/2003US20030004346 Synthesis of substituted pyrazolopyrimidines
01/02/2003US20030004196 Antiinflamamtory agents; autoimmune disease
01/02/2003EP1268414A1 Ceramide derivatives and method of use
01/02/2003EP1268404A1 Malonamic acids and derivatives thereof as thyroid receptor ligands
01/02/2003EP1268403A1 Method for the beckmann rearrangement of organic oximes
01/02/2003EP1268400A2 Method for producing n-butyryl-4-amino-3-methyl-methyl benzoate and the novel compound n-(4-bromine-2-methylphenyl)-butanamide
01/02/2003EP1268051A2 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
12/2002
12/31/2002US6500986 Racemization of optically active amides; conversion to amines
12/31/2002US6500980 Process for preparing amino derivatives of C-H-acid compounds
12/31/2002US6500849 Administering antiinflammatory, antiproliferative, nootropic or antigrowth agents, such as 6-(1-dodecynyl)-2-pyridine-carboxaldehyde and enantiomorphs to mammals; alzheimers disease
12/31/2002US6500791 Personal care products comprising quaternized dialkyl amidoamines
12/31/2002CA2163614C Method of producing a taxane-type diterpene
12/27/2002WO2002103103A2 Fluorine-containing compounds and polymers derived therefrom
12/27/2002WO2002102758A1 Fluorine-containing compounds and polymers derived therefrom
12/27/2002WO2002072540A3 Improved methods of ortho alkylation
12/27/2002WO2002036261B1 Catalyst comprising a chiral cationic metal-ligand complex immobilised on a mesoporous alumino-silicate support, its preparation and use in asymmetric hydrogenation
12/27/2002CA2451547A1 Fluorine-containing compounds and polymers derived therefrom
12/27/2002CA2451542A1 Fluorine-containing compounds and polymers derived therefrom
12/26/2002US20020198399 Useful as intermediates or raw materials for the synthesis of agricultural chemicals, pharmaceuticals
12/26/2002US20020198251 Substituted 2-dialkylaminoalkylbiphenyl derivatives
12/26/2002US20020198245 Heterocyclic aromatic oxazole compounds and use thereof
12/26/2002US20020198244 Heterocyclic aromatic oxazole compounds and use thereof
12/25/2002CN1387505A Compositions contg. hydroxyeicosatetraenoic acid derivs, and methods of use in treating dry eye disorders
12/24/2002US6498276 Reacting amido acetic acid derivative with thionyl chloride to form oxazole compound which is reacted with halobenzoly compound
12/24/2002US6498274 Amide derivatives for the treatment of diseases mediated by cytokines
12/24/2002US6498256 Catalysts for asymmetric addition reactions, for example of hydrogen, to prochiral unsaturated organic compounds.
12/24/2002US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same
12/24/2002US6498180 Such as 2-(3'-hydroxymethyl-2'-carboxycyclopropyl)glycine; modulating metabotropic glutamate receptor; treating disorders of central nervous
12/24/2002US6498004 Silver halide light sensitive emulsion layer having enhanced photographic sensitivity
12/19/2002WO2002100846A1 Compounds and methods for the treatment or prevention of flavivirus infections
12/19/2002WO2002100824A1 A novel alkaloid derivative and a pharmaceutical composition containing the same
12/19/2002WO2002100818A2 Aminediols as agents for the treatment of alzheimer's disease
12/19/2002WO2002100813A2 Modulators of peroxisome proliferator activated receptors
12/19/2002WO2002100812A1 Carboxylic acid derivative and salt thereof
12/19/2002WO2002100403A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/19/2002WO2002100341A2 Compounds for the treatment of metabolic disorders
12/19/2002WO2002059080A3 Trisubstituted carbocyclic cyclophilin binding compounds and their use
12/19/2002WO2002042248A3 Naphthalene derivatives
12/19/2002US20020193604 Aryl borates
12/19/2002US20020193414 Adamantane derivatives
12/19/2002US20020193269 As precursors for organoleptic agents, such as fragrances, and masking agents and for antimicrobial agents
12/19/2002US20020189033 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same
12/19/2002CA2450205A1 Aminediols for the treatment of alzheimer's disease
12/19/2002CA2449256A1 Modulators of peroxisome proliferator activated receptors
12/19/2002CA2448552A1 Modulators of peroxisome proliferator activated receptors (ppar)
12/18/2002EP1265839A1 Compounds active at the glucocorticoid receptor
12/18/2002EP1265606A1 Cell adhesion inhibitors
12/18/2002EP0936865B1 Stable aqueous formulation of 3-(n-butylacetamino)-propionic acid ethyl ester
12/18/2002CN1385416A Gel factor and molecular gel obtained from it
12/17/2002US6495704 Process for the preparation of a derivative or analog of baccatin iii or 10-desacetyl baccatin iii having a c9 substituent other than keto in which the c9 keto substituent of taxol, a taxol analog, baccatin iii or 10-desacetyl
12/17/2002US6495681 Local anesthetic compounds and uses
12/17/2002US6495645 Incorporating many side functional groups while maintaining sensitive temperature response
12/17/2002US6495576 N-(1-((3,4-dioxo-2-(3-pyridinylamino)-1-cyclobuten-1-yl)amino) -2,2-dimethylpropyl)-4-methylbenzamide for example; treating bladder overactivity, benign prostatic hyperplasia, premature labor, and sexual disorders
12/17/2002US6495546 Propanolamine derivatives
12/17/2002CA2064783C Cytoprotective fatty moiety compounds
12/12/2002WO2002098850A2 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002WO2002098840A1 Carboxylic acid derivative and medicine comprising salt or ester of the same
12/12/2002WO2002098839A1 Biphenylcarboxamides and process for preparation thereof
12/12/2002WO2002083090A3 Novel coupling components for oxidative hair colouring
12/12/2002WO2002066415A3 Non-steroidal modulators of estrogen receptors
12/12/2002US20020188153 Apparatus and process for the high yield production of methyl methacrylate or methacrylic acid
12/12/2002US20020188144 Cosmetic composition comprising an amide, and novel amides
12/12/2002US20020188136 Pesticides and herbicides
12/12/2002US20020188133 Producing an isoxazolidinedione compound from beta - methyl L-aspartate via an important intermediate oxazolylethanol derivative
12/12/2002US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002US20020188111 For photodynamic therapy of a lesion; medical diagnosis; drug screening; bioavailability
12/12/2002US20020188084 Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same
12/12/2002US20020187542 Fatty-acid amide hydrolase
12/12/2002CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/11/2002WO2001095721A2 Use of phenethyl acrylamides, novel phenethyl acrylamides, and method for producing the same
12/11/2002EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002EP1264820A1 Novel amide compounds
12/11/2002EP1263849A1 Degradable cross-linking agents and cross-linked network polymers formed therewith
12/11/2002EP1263730A1 Amine derivatives for the treatment of apoptosis
12/11/2002EP1061956B1 Manganese chelates with high relaxivity in serum
12/11/2002EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines
12/11/2002EP0966436B1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
12/11/2002EP0934257B1 Substituted n-arylmethylamino derivatives of cyclobutene-3,4-diones
12/11/2002EP0752813B1 Inhibitors of metazoan parasite proteases
12/11/2002EP0624155B2 Carbamates and plant-protecting agents containing them
12/11/2002CN1384817A Polymorphic N-[3-[[2-(3,4-dimethyoxyphenyl)ethyl]amino]propyl]-4-nitro benzamide hydrochloride
12/11/2002CN1384814A Phenoxy carboxylic acid compounds and compositions for delivering active agents
12/11/2002CA2412489A1 Use of phenethyl acrylamides, novel phenethyl acrylamides, and method for producing the same
12/10/2002US6492555 Reaction of a carbamate with either a (s)-secondary alcohol or (s)-epoxide or (s)-ester; bactericides
12/10/2002US6492547 Carboxylic acid amides, pharmaceutical compositions containing these compounds, their use and the preparation thereof
12/10/2002US6492544 Process for synthesis of enantiomerically enriched β-amino acids
12/10/2002US6492424 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders
12/10/2002US6492423 Hepatitis c and b viricides
12/10/2002US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
12/10/2002US6492355 Adamantane derivatives